Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Cytochrome P450 3A4 |
---|
Ligand | BDBM50019654 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1361156 (CHEMBL3292130) |
---|
IC50 | >50000±n/a nM |
---|
Citation | Shirude, PS; Shandil, RK; Manjunatha, MR; Sadler, C; Panda, M; Panduga, V; Reddy, J; Saralaya, R; Nanduri, R; Ambady, A; Ravishankar, S; Sambandamurthy, VK; Humnabadkar, V; Jena, LK; Suresh, RS; Srivastava, A; Prabhakar, KR; Whiteaker, J; McLaughlin, RE; Sharma, S; Cooper, CB; Mdluli, K; Butler, S; Iyer, PS; Narayanan, S; Chatterji, M Lead optimization of 1,4-azaindoles as antimycobacterial agents. J Med Chem57:5728-37 (2014) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 3A4 |
---|
Name: | Cytochrome P450 3A4 |
Synonyms: | Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase |
Type: | Enzyme |
Mol. Mass.: | 57349.57 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 503 |
Sequence: | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF
DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI
AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS
MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV
FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI
IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV
NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS
KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG
GLLQPEKPVVLKVESRDGTVSGA
|
|
|
BDBM50019654 |
---|
n/a |
---|
Name | BDBM50019654 |
Synonyms: | CHEMBL3109802 |
Type | Small organic molecule |
Emp. Form. | C18H21N5O3 |
Mol. Mass. | 355.391 |
SMILES | COc1ncnc(Cn2cc(C(=O)NCCO)c3ncc(C)cc23)c1C |
Structure |
|